Oxford Nanopore User Group Meeting, NYC

Lauren currently supervises the Cytogenetics Laboratory and is involved in R&D in the Laboratory of Clinical Genomics and Advanced Technology CGAT at Dartmouth-Hitchcock Medical Center. In her current position, she is active in overseeing the clinical testing in the cytogenetics laboratory. Lauren’s research interests center around hematology and clinical implementation of long read sequencing technology. Lauren obtained her PhD in Molecular and Cell Biology from University of Connecticut in 2022 where she applied nascent RNA sequencing methods to examine enhancer function in hematological diseases. She subsequently completed the Molecular Diagnostics Fellowship at Dartmouth-Hitchcock Medical Center in 2024.

oseph Shea is a research scientist in the Mycobacteriology Laboratory at the Wadsworth Center, New York State Department of Health. After working in a food manufacturing lab, Joseph began working with tuberculosis while completing a master’s degree in lab sciences to pursue a career in public health. His research interests include antimicrobial resistance and molecular epidemiology of M. tuberculosis complex and zoonotic tuberculosis.

Joseph M. Tripodi, Ph.D., is Assistant Professor and Associate Director of the Tumor Cytogenomics Laboratory at the Icahn School of Medicine at Mount Sinai. A clinical cytogeneticist specializing in hematologic malignancies, he directs karyotyping, FISH, and microarray testing and is evaluating Oxford Nanopore long-read sequencing as a unified next-generation cytogenomic assay.

I am an Assistant Professor at the University of Pennsylvania and board certified Laboratory Director in the Genomic Diagnostics Laboratory and Center for Diagnostic Innovation at the Children's Hospital of Philadelphia. There, I lead the development and validation of new technologies and assays for cancer genomics.

Feng Xu, PhD, is a clinical genomics scientist at Children’s Hospital of Philadelphia. Her work focuses on the development and clinical translation of emerging molecular technologies for cancer genomic diagnostics and precision medicine.

Lauren currently supervises the Cytogenetics Laboratory and is involved in R&D in the Laboratory of Clinical Genomics and Advanced Technology CGAT at Dartmouth-Hitchcock Medical Center. In her current position, she is active in overseeing the clinical testing in the cytogenetics laboratory. Lauren’s research interests center around hematology and clinical implementation of long read sequencing technology. Lauren obtained her PhD in Molecular and Cell Biology from University of Connecticut in 2022 where she applied nascent RNA sequencing methods to examine enhancer function in hematological diseases. She subsequently completed the Molecular Diagnostics Fellowship at Dartmouth-Hitchcock Medical Center in 2024.

Joseph M. Tripodi, Ph.D., is Assistant Professor and Associate Director of the Tumor Cytogenomics Laboratory at the Icahn School of Medicine at Mount Sinai. A clinical cytogeneticist specializing in hematologic malignancies, he directs karyotyping, FISH, and microarray testing and is evaluating Oxford Nanopore long-read sequencing as a unified next-generation cytogenomic assay.

oseph Shea is a research scientist in the Mycobacteriology Laboratory at the Wadsworth Center, New York State Department of Health. After working in a food manufacturing lab, Joseph began working with tuberculosis while completing a master’s degree in lab sciences to pursue a career in public health. His research interests include antimicrobial resistance and molecular epidemiology of M. tuberculosis complex and zoonotic tuberculosis.